IRIS
MANTOVANI, LORENZO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 697
EU - Europa 570
AS - Asia 169
AF - Africa 36
SA - Sud America 2
OC - Oceania 1
Totale 1.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 683
IT - Italia 149
CN - Cina 147
UA - Ucraina 130
FI - Finlandia 82
IE - Irlanda 62
NL - Olanda 51
DE - Germania 47
CI - Costa d'Avorio 25
GB - Regno Unito 25
SE - Svezia 15
CA - Canada 14
IN - India 8
ZA - Sudafrica 7
SG - Singapore 4
CH - Svizzera 3
KR - Corea 3
AR - Argentina 2
EG - Egitto 2
FR - Francia 2
IQ - Iraq 2
JP - Giappone 2
PL - Polonia 2
AT - Austria 1
AU - Australia 1
GR - Grecia 1
IR - Iran 1
KZ - Kazakistan 1
MZ - Mozambico 1
NG - Nigeria 1
PK - Pakistan 1
Totale 1.475
Salva come PNG Salva come JPEG
Città #
Jacksonville 125
Chandler 86
Princeton 80
Napoli 79
Nanjing 57
Boston 53
Amsterdam 50
Millbury 45
Wilmington 28
Des Moines 23
Beijing 19
Ashburn 17
Jiaxing 17
Hebei 15
Nanchang 14
Falls Church 10
Norwalk 10
Shenyang 10
Naples 8
Changsha 6
Dublin 6
Lawrence 6
Rome 6
Cape Town 5
Indiana 5
Rohtak 5
Houston 4
Krefeld 4
London 4
Tianjin 4
Ann Arbor 3
Marrero 3
Maxville 3
Pisa 3
Pune 3
Pyeongtaek-si 3
Singapore 3
Woodbridge 3
Boardman 2
Bologna 2
Cairo 2
Edenderry 2
Freiburg im Breisgau 2
Kronberg 2
Lappeenranta 2
Mason City 2
Milan 2
Monza 2
Orange 2
Ottawa 2
Paris 2
Polska 2
Redmond 2
Redwood City 2
Sulaymaniyah 2
Tokyo 2
Toronto 2
Victoria 2
Westland 2
Yellow Springs 2
Zurich 2
Athens 1
Austin 1
Basel 1
Buenos Aires 1
Camparada 1
Chicago 1
Cork 1
Corpus Christi 1
Dartmouth 1
Drogheda 1
Eindhoven 1
Formia 1
Hickory Hills 1
Hobart 1
Huntington 1
Johannesburg 1
Kohat 1
Kunming 1
Lagos 1
Lake Havasu City 1
Levelland 1
Lissone 1
Los Angeles 1
Matteson 1
Montecarotto 1
Mountain View 1
Munro 1
New York 1
Pavia 1
Poggiomarino 1
Saint Louis 1
San Francisco 1
San Mateo 1
San Severino Marche 1
Sandton 1
Saskatoon 1
Seattle 1
Shreveport 1
Simi Valley 1
Totale 910
Salva come PNG Salva come JPEG
Nome #
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019 79
Valutazione economica dello studio AVERT 53
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 43
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 43
Malattia di Alzheimer in Italia: impatto sociale, sanitario ed economico. Farmacoeconomia 28
Assistenza Territoriale 28
Cost-Benefit Analysis of Amtolmetin-Guacil 27
Farmacoeconomia 27
A proposal for Italian Guidelines in pharmacoeconomics 26
Captopril in the management of patients after acute myocardial infarction. A cost-effectiveness analysis in Italy 26
Valutazione farmacoeconomica dell’uso di tramadolo vs ketorolac nella gestione del dolore postoperatorio 26
Caring for patients with Alzheimer’s disease in Italy 25
Can Europe afford not to implement evidence-based medicine in heart failure? 24
Pharmaco-economic aspects of recombinant FSH in women undergoing in-vitro fertilisation in Italy 23
Guidelines for economic evaluations in Italy: recommendations from the italian group of pharmacoeconomic studies 23
Evaluation of scientific research concerning health in the less favored regions of the European Union: health care in three southern Member States (Spain, Greece and Italy) 23
Adherence to antihypertensive medications and cardiovascular morbidity among newly-diagnosed hypertensive patients 23
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study. 23
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 23
Francia 22
I farmaci generici: aspetti chiave e situazione internazionale 22
KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting. 22
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment. 22
Is preventive medical care worth the cost? 21
The cost of caring for patients with Psoriasis in Italy: results from the AISP Study 20
Do different physicians' panels reach similar conclusions? A case study on practice guidelines for limited surgery in breast cancer 20
L-Carnitine use in hemodialiyed patients 20
Good economic practices per gli studi di farmacoeconomia 20
Germania 20
Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective 20
Efficiency measures of emergency departments: an Italian systematic literature review 20
Trattamento con etanercept dei soggetti con artrite reumatoide in Italia: considerazioni economiche 19
Caring for patients with Alzheimer's disease in Italy 19
Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. 19
Cost Minimization Analysis of Radiofrequency Compared to Laser Thermal Ablation in Patients with Hepatocellular Carcinoma 19
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group 18
Quadro Teorico di Riferimento 18
Costi e disabilità nei pazienti anziani oncologici 18
Valutazione economica dello studio CARDS, aggiornamenti. 18
Burden of acute myocardial infarction 17
The social burden and quality of life of patients with haemophilia in Italy. 17
Cost Analysis of Capecitabine vs 5-Fluorouracil-Based Treatment for Metastatic Colorectal Cancer Patients 16
An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom 16
Clinical epidemiology of hand eczema in patients accessing dermatological reference centers: results from a Mediterranean Country. 16
The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients. 16
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 16
Comparative analysis of the pivotal studies of extended half-life recombinant FVIII products for treatment of haemophilia A 16
Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact. 15
Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy 15
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 14
Italian population-based values of EQ-5D health states. 14
Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. 14
The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. 14
Cost-Effectiveness Analysis of New Drugs for Chronic Hepatitis C: The Importance of Updating Utility Values. 13
Management of treatment-na?ve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options. 13
Uncovered needs in the management of inherited bleeding disorders in Italy. 13
Use of health-related quality-of-life measurements to estimate individuals' health on screening. 13
Healthcare costs associated with hepatocellular carcinoma and the value of care. 13
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. 13
The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature 12
The importance of baseline viral load when assessing relative efficacy in treatment-na?ve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis. 12
Haemophilia Care in Europe: the ESCHQoL study 11
Present and future challenges in the treatment of haemophilia: the patient's perspective. 11
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study. 11
Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis. 11
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). 11
The perspective of a pharmacoeconomic study: Targeting for audiences 10
Haemophilia prophylaxis: how can we justify the costs? 10
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: An extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 10
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 10
Is preventive medical care worth the cost? 9
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors 9
The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study 9
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. 8
L-carnitine use in hemodialyzed patients 8
Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study 8
Cost-effectiveness of different diagnostic strategies to assess gastro-oesophageal reflux disease in patients with unexplained chronic persistent cough in Italy 7
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors 7
Oral antiviral therapies are cost-effective vs. no treatment but indirect comparisons should be avoided 7
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group 6
Guidelines for economic evaluations in Italy: Recommendations from the Italian Group of Pharmacoeconomic Studies 6
Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients 6
Setting dialysis start at 6.0 ml/min/1.73 m(2) eGFR-a study on safety, quality of life and economic impact 6
New pharmacoeconomic option in uremic anemia management 6
Quality of life assessment in clinical practice in haemophilia treatment 5
Major complications have an impact on total annual medical cost of diabetes - Results of a database analysis 5
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment 5
Pharmaco-economic aspects of in-vitro fertilization in Italy 5
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 5
Totale 1.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 0 3
2019/2020237 126 2 25 2 25 2 0 3 5 5 18 24
2020/2021218 0 24 28 29 25 33 25 0 27 1 26 0
2021/2022299 1 0 6 0 0 16 0 14 55 34 21 152
2022/2023361 88 22 22 5 12 22 0 66 48 50 24 2
2023/2024182 11 45 29 13 14 9 14 39 4 4 0 0
Totale 1.530